US approves first drug for rare genetic neurological disorder
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Sanofi’s oral drug venglustat – the first treatment approved for a type of rare genetic condition affecting the brain and nervous system. The drug, Infilbray (venglustat) tablets, is approved to first neurological symptoms of type 3 Gaucher disease (GD3) in patients weighing at least 15 kg (about 33 pounds). FDA approves drug for rare neurological disorder According to the FDA, GD3 is a rare, inherited condition in which the body
Advanced analysis (spheres, detailed sources, paid analyses)
Covered mainly by the Global South sphere (100%); silent in Western, Sino-Russian & BRICS, Arab-Muslim world.
Global sphere reading. The left / centre / right reading is shown in the coverage analysis below.
- Confirmed by 5 outlets in 1 countries.
- Ignored by Western, Sino-Russian & BRICS, Arab-Muslim world.
- Propagation: first reported by fox26houston.com (Georgia), . 5 outlets republished 1 headline word for word.
Headline clash across the four spheres
No outlet in this sphere covers the event: blind spot.
No outlet in this sphere covers the event: blind spot.
No outlet in this sphere covers the event: blind spot.
- US approves first drug for rare genetic neurological disorderfox26houston.com · Georgia
- US approves first drug for rare genetic neurological disorderfox13news.com · Georgia
Coverage analysis
Analyzing coverage…
Event sources
- US approves first drug for rare genetic neurological disorderfox26houston.comGeorgiaGeorgia → GeorgiaEnglish
- US approves first drug for rare genetic neurological disorderfox13news.comGeorgiaGeorgia → GeorgiaEnglish
- US approves first drug for rare genetic neurological disorderlivenowfox.comGeorgiaGeorgia → United StatesEnglish
- US approves first drug for rare genetic neurological disorderfox35orlando.comGeorgiaGeorgia → GeorgiaEnglish
- US approves first drug for rare genetic neurological disorderfox5atlanta.comGeorgiaGeorgia → GeorgiaEnglish